(Q43433320)

23 November 2017

Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin (English)

1 reference

23 November 2017

1 reference

Mingyu Lv

1

1 reference

23 November 2017

Jiawen Wang

2

1 reference

23 November 2017

Yingzi Zhu

3

1 reference

23 November 2017

Xiaodan Wang

4

1 reference

23 November 2017

Tao Zuo

5

1 reference

23 November 2017

Donglai Liu

6

1 reference

23 November 2017

Jingyao Zhang

7

1 reference

23 November 2017

Jiaxin Wu

8

1 reference

23 November 2017

Haihong Zhang

9

1 reference

23 November 2017

Wei Kong

10

1 reference

23 November 2017

Xianghui Yu

11

1 reference

23 November 2017

language of work or name

English

0 references

publication date

28 November 2012

1 reference

23 November 2017

1 reference

23 November 2017

587

1 reference

23 November 2017

1

1 reference

23 November 2017

37-43

1 reference

Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Small-molecule inhibition of HIV-1 Vif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Structural insight into the mechanisms of enveloped virus tethering by tetherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Tetherin inhibits HIV-1 release by directly tethering virions to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Vpu matchmakers as a therapeutic strategy for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Tetherin restricts productive HIV-1 cell-to-cell transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

BST-2 diminishes HIV-1 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.11.022

10.1016/J.FEBSLET.2012.11.022

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference